» Articles » PMID: 28781656

Radiological and Clinical Features of Primary NK/T-cell Lymphoma Involving the Whole Length of the Esophagus: A Case Report

Overview
Journal Oncol Lett
Specialty Oncology
Date 2017 Aug 8
PMID 28781656
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Primary esophageal natural killer (NK)/T-cell lymphoma is a markedly rare tumor. There were only 6 cases of the disease identified prior to June 2015. In the present study, the aforementioned cases were validated, and relevant computed tomography (CT) results and clinical features of primary esophageal NK/T-cell lymphoma were determined, to increase awareness of this type of tumor. CT features and clinical presentations of a patient with pathologically confirmed esophageal NK/T-cell lymphoma was analyzed. The patient exhibited non-specific clinical symptoms and CT images revealed diffuse thickening of the entire length of the esophagus. The patient received cycles of systemic chemotherapy and subsequent chest CT images demonstrated prompt and marked shrinkage of the tumor. At the time of writing, the patient has survived for 24 months and experiences a good quality of life without postprandial fullness or difficulty swallowing solid food. In addition, the characteristics of 6 patients with complete clinical features of this type of tumor, on the basis of a review of published studies (online PubMed, Medline, Google Scholar, Chinese Biomedicine Database and China Journal Full Text Database search), were retrospectively analyzed. Although primary esophageal NK/T-cell lymphoma is a markedly rare tumor, it is considered to be included in differential diagnosis of patients presenting with a fungal or viral infection, therapy-related mucositis or reflux esophagitis. The final diagnosis of primary esophageal NK/T-cell lymphoma is on the basis of a combination of clinical, CT and histopathological results.

Citing Articles

Treatment of primary esophageal lymphomas: A review.

El Khoury J, Daou R, Kim N, Bou Eid J, Imber B, Yahalom J Front Oncol. 2025; 15:1475153.

PMID: 39980557 PMC: 11839416. DOI: 10.3389/fonc.2025.1475153.


Non-Hodgkin's Lymphoma Presenting as Esophageal Stenosis in a Pediatric Patient.

Lee J, Khan H, McBee M, Kasi N JPGN Rep. 2023; 3(3):e213.

PMID: 37168637 PMC: 10158407. DOI: 10.1097/PG9.0000000000000213.


Primary Esophageal Lymphoma: A Histopathological Experience from Two Tertiary Hospitals, Western Saudi Arabia.

Al-Maghrabi J, Al-Maghrabi S Gastroenterol Res Pract. 2023; 2023:7302344.

PMID: 36756091 PMC: 9902162. DOI: 10.1155/2023/7302344.


Primary Esophageal Lymphoma: Clinical Experience in Diagnosis and Treatment.

Qu J, Zhuang Y, Zheng D, Huang F, Zhang S Cureus. 2021; 13(9):e17628.

PMID: 34646677 PMC: 8486375. DOI: 10.7759/cureus.17628.


Primary esophageal non-Hodgkin's lymphoma: demographics, clinical characteristics, histopathologic types, and survival in 179 patients from the SEER program and systematic review of the literature.

Quiroga-Centeno A, Bautista-Parada I, Tapias L, Gomez-Ochoa S Esophagus. 2021; 18(4):734-742.

PMID: 33880688 DOI: 10.1007/s10388-021-00842-0.


References
1.
Kim J, Lee J, Oh S, Chang D, Rhee P, Kim J . Primary NK-/T-cell lymphoma of the gastrointestinal tract: clinical characteristics and endoscopic findings. Endoscopy. 2007; 39(2):156-60. DOI: 10.1055/s-2006-945114. View

2.
Bandyopadhyay S, Moulick A, Dutta A . Primary duodenal lymphoma producing obstructive jaundice. J Assoc Physicians India. 2007; 55:76-7. View

3.
Kurihara K, Fukui A, Kumano S . Malignant lymphoma of the esophagus associated with macroglobulinemia: report of a case. Pathol Int. 1994; 44(9):712-5. DOI: 10.1111/j.1440-1827.1994.tb02951.x. View

4.
Wu X, Li P, Zhao J, Yang X, Wang F, Yang Y . A clinical study of 115 patients with extranodal natural killer/T-cell lymphoma, nasal type. Clin Oncol (R Coll Radiol). 2008; 20(8):619-25. DOI: 10.1016/j.clon.2008.05.011. View

5.
Crook T, Robinson R . Dysphagia in a patient with a history of large B-cell lymphoma: esophageal disease with negative biopsy findings. Diagn Cytopathol. 2002; 26(3):167-9. DOI: 10.1002/dc.10078. View